Roots Analysis

FEBRUARY 24, 2022

In addition to therapeutics, these complex molecules act as a significant resource in various research applications. The overall manufacturing of oligonucleotides involves the following steps. The post Accelerating Oligonucleotide Demand: A Force Driving The Contract Manufacturing Market appeared first on Blog. Web: [link].

Contract Manufacturing 52

Contract Manufacturing Manufacturing Marketing Drug Delivery Systems 52

Roots Analysis

FEBRUARY 18, 2022

In the 20 th century, major research went into discovery of a therapeutic class with the primary purpose of interfering with the RNA expression linked to disease causing proteins, nowadays classified as oligonucleotides. Companies based in Asia-Pacific are increasingly undertaking initiatives in order to expand their manufacturing capacities.

Contract Manufacturing 52

Contract Manufacturing Manufacturing Drug Delivery Systems RNA 52

XTalks

MAY 30, 2023

The VTT Technical Research Centre of Finland has addressed this issue by developing a fully recyclable, modular ECG patch constructed from VTT’s novel cellulose e-skin material. Aayush Jaiswal, research scientist at VTT said, “Ours is the first nanocellulose-based ECG patch with no plastic additives.

Drug Delivery 98

Drug Delivery Drug Delivery Systems Manufacturing Contamination 98

Roots Analysis

MARCH 16, 2022

Over the years, applications of exosomes in therapeutics have undergone an evolutionary change, in terms of cost of research, technology used, and duration of the study. Published Scientific Literature: Indicative of the Ongoing pace of Research in this Field. Future Evolution of Exosome Development and Manufacturing Services Market.

Marketing 59

Marketing Manufacturing Drug Delivery Drug Delivery Systems 59

Roots Analysis

FEBRUARY 14, 2023

In recent years, liposomes have garnered significant interest of researchers, as well as industry players, owing to their potential in diagnosis and treatment of various diseases, with a focus on delivering drugs and genetic material. Majority of the articles (51%) are focused on evaluating liposomes for use in cancer therapy.

Development 52

Development Manufacturing Drug Delivery Systems Contract Manufacturing 52

Roots Analysis

FEBRUARY 13, 2023

As a result, there is an evident increase in the demand for mRNA manufacturing capacity. Application of Synthetic mRNA Several studies conducted by healthcare companies and research institutions have demonstrated the potential of mRNA.

Manufacturing 52

Manufacturing Drug Delivery Systems Genetic Engineering RNA 52

Roots Analysis

FEBRUARY 20, 2022

Amidst the current initiatives to develop therapeutic interventions with improved bioavailability, nanoparticles have specifically captured the interest of researchers and drug developers, given their ability to act as drug carriers for complex and highly promising therapeutics.

Contract Manufacturing 52

Contract Manufacturing Bioavailability Manufacturing Drug Delivery Systems 52

Roots Analysis

MARCH 24, 2022

However, research related to metabolites is essential to increase the understanding of molecular level interactions, functions, modifications and regulations in cells, therefore, the field of metabolomics plays a vital role in biomarker discovery for early disease diagnosis and prognosis as well as for drug discovery and development processes.

Clinical Research 52

Clinical Research Development Research Drug Delivery Systems 52

Roots Analysis

FEBRUARY 18, 2022

Over time, many research studies have shown that myeloid cells can interact with the immune system and aid in generating an appropriate anti-tumor immune response. Over 10,000 articles, indicative of the ongoing research and innovation in this field, have been published in scientific literature. ACADEMIC GRANTS ANALYSIS.

Drug Delivery Systems 52

Drug Delivery Systems Immune Response Clinical Trials Clinical Trials 52

Roots Analysis

FEBRUARY 26, 2024

Likewise, there are several other targets that have not yet been successfully drugged and researchers are making significant efforts to identify novel approaches to target them. As a result, novel product development opportunities have emerged and are likely to benefit both drug developers and investors alike.

Drug Delivery Systems 52

Drug Delivery Systems Marketing Drug Delivery Development 52

Roots Analysis

OCTOBER 5, 2023

Driven by the increasing need for safe and efficient medical devices and drug delivery systems, the pharmaceutical polymers / medical grade polymers domain is advancing significantly. There has been a rise in the development of polymers for biopharma with improved biocompatibility, biodegradability and functionality.

Manufacturing 40

Manufacturing Drug Delivery Systems Drug Delivery Packaging 40

Roots Analysis

MARCH 3, 2022

Published Scientific Literature: Indicative of the Ongoing pace of Research in this Field. High Number of Patents are Suggestive of the Widespread Research in this Domain. Next Generation Complement Therapeutics. Next Generation Complement Therapeutics. For further information on this domain, check out the report –. Web: [link].

Drug Delivery Systems 52

Drug Delivery Systems Marketing Immune Response Dermatology 52

Roots Analysis

MARCH 2, 2022

Oral Protein / Peptide-based Drugs. Clinical Research Landscape of Oral Peptide and Protein-based Therapeutics. You may also be interested in the following titles: Live Biotherapeutic Products and Microbiome Manufacturing Marke t Next Generation Complement Therapeutics Market Intranasal Therapeutics and Drug Delivery Systems Market.

Protein 52

Protein Drugs Drug Delivery Drug Delivery Systems 52

The Pharma Data

SEPTEMBER 1, 2021

With a goal of developing rheumatoid arthritis therapies with minimal side effects, researchers at Washington University School of Medicine in St. Louis have genetically engineered cells that, when implanted in mice, will deliver a biologic drug in response to inflammation. million adults in the United States.

Drugs 52

Drugs Engineer Drug Delivery Gene 52

Delveinsight

NOVEMBER 29, 2020

Therapies such as dexamethasone drug delivery system and vascular endothelial growth factor inhibitors have already pierced deeper into the market. The drug if approved will help minimize the use of unapproved repackaged IV bevacizumab from compounding pharmacists for retinal disease.

Marketing 52

Marketing Drug Delivery Pharma Companies Clinical Trials 52

Roots Analysis

MAY 21, 2024

Amidst the ongoing initiatives to develop therapeutic interventions with improved bioavailability, lipid nanoparticle (LNPs) have specifically attracted the attention of researchers and drug developers. The LNPs can be monitored using various imaging modalities to confirm the delivery of siRNA to the target cells.

Drug Delivery 40

Drug Delivery Drugs Gene Therapy Bioavailability 40

Roots Analysis

SEPTEMBER 13, 2023

Conjugation with a Variety of Molecular Conjugates and Labels The combination of the conjugates / labels with molecules ( proteins, peptides, antibodies and small molecules ) is being used abundantly for several applications, ranging from therapeutics and diagnostics to isolation and characterization of drug delivery systems.

Development 40

Development Antibody Protein Drug Delivery Systems 40

Drug Patent Watch

DECEMBER 19, 2024

A robust drug patent portfolio is not just an assetit’s a critical tool for success. As companies invest billions in research and development, protecting their innovations through strategic patent management has become more important than ever. This creates a web of protection that’s difficult for competitors to navigate.

Drugs 92

Drugs Marketing Licensing Licensing 92